שבת, נובמבר 21, 2026 עברית|English Log in Free sign-up
LIVE
NYC Mayor Mamdani tears Achilles tendon after scoring goal during soccer game against journalistsBeyond the tent: How haredim can bring their Torah into Israel’s shared life – opinionLiberman slams report Knesset adviser opposes his haredi draft plan as ‘a lie and a falsehood’US warns of al-Qaeda calls to copy flydubai hijacking attempt ahead of Thanksgiving – report13-year-old shot dead at close range on his way to school in East Jerusalem’s Shuafat6 Palestinians wounded in Israeli ceasefire violations across GazaTen-year-old boy shot dead in front of students while walking to school in ShuafatThree people said killed in Israeli strike on Gaza City; no comment from IDFAfter US midterm losses, Jewish conservatives confront a changing political landscapeYemen’s Houthis fire 3 missiles at Riyadh after Saudi coalition’s ‘special operation’Satellite images reveal UAE military buildup at Somali airfields – reportMyanmar Genocide Ruling Challenges Israel’s Defence of Its War in GazaNYC Mayor Mamdani tears Achilles tendon after scoring goal during soccer game against journalistsBeyond the tent: How haredim can bring their Torah into Israel’s shared life – opinionLiberman slams report Knesset adviser opposes his haredi draft plan as ‘a lie and a falsehood’US warns of al-Qaeda calls to copy flydubai hijacking attempt ahead of Thanksgiving – report13-year-old shot dead at close range on his way to school in East Jerusalem’s Shuafat6 Palestinians wounded in Israeli ceasefire violations across GazaTen-year-old boy shot dead in front of students while walking to school in ShuafatThree people said killed in Israeli strike on Gaza City; no comment from IDFAfter US midterm losses, Jewish conservatives confront a changing political landscapeYemen’s Houthis fire 3 missiles at Riyadh after Saudi coalition’s ‘special operation’Satellite images reveal UAE military buildup at Somali airfields – reportMyanmar Genocide Ruling Challenges Israel’s Defence of Its War in Gaza
World

Israeli blood test could make lung-cancer detection faster, more accessible

אוג 11, 2026 ·  Source: JNS 86Objectivity score86/100

Israeli blood test could make lung-cancer detection faster, more accessible

Israeli scientists have developed a blood test that can detect lung cancer without DNA sequencing, potentially offering a faster and less expensive tool to complement existing imaging methods, Tel Aviv University announced on Monday.“Our goal is to make blood tests for cancer diagnosis more accessible, simpler and less expensive without compromising accuracy,” said Professor Yuval Ebenstein of the university’s School of Chemistry. “We have developed a new approach that does not require genetic sequencing but instead identifies the tumor’s chemical ‘fingerprint’ with light, using a technology that can be implemented in standard clinical laboratories.”Lung cancer is the leading cause of cancer-related deaths worldwide. Diagnosis currently relies heavily on CT scans, which can identify suspicious areas but also produce many findings that ultimately prove benign. Such findings can lead to unnecessary biopsies and surgeries.Liquid biopsies offer another approach, but many rely on DNA sequencing, which can be costly and require sophisticated…

💬 רוצים להגיב ולהצטרף לדיון? הצטרפו — חינם, ומקבלים גם את הדיג׳סט השבועי.
🗞️ In-depth summary

Israeli scientists at Tel Aviv University have developed a new blood test for lung cancer that identifies a chemical "fingerprint" of cancer cells without requiring DNA sequencing. This technology aims to provide a faster, more accessible, and less expensive diagnostic tool to complement existing imaging methods like CT scans. Professor Yuval Ebenstein stated, "Our goal is to make blood tests for cancer diagnosis more accessible, simpler and less expensive without compromising accuracy."

  • The test achieved 93.1% sensitivity and 90.3% specificity in distinguishing lung cancer patients from healthy individuals in a study of 103 participants with Stage 2-4 disease.
  • It can potentially differentiate between adenocarcinoma and squamous cell carcinoma, two major forms of lung cancer.
  • Preliminary findings suggest the technology could monitor patient responses to treatment, with changes in the DNA fingerprint correlating with imaging results.
  • The test takes two to three days and costs approximately $60 per sample, making it potentially more accessible than some current liquid biopsy methods.
Automatically generated summary based on the original article; quotes are from the source.
This story is based on reporting by JNS.
Read the full article at the source →
🏷

© All rights to the original article belong to the source. Din Online shows a headline, an excerpt and a link only. The objectivity rating is computed automatically and is an estimate only.

Related

Discussion

No comments yet — be the first to comment.

Add a comment